Expression of IP and PPARγ decreases in the pulmonary arteries of patients with PAH, compared with unaffected individuals (Ameshima et al., 2003; Falcetti et al., 2010), and this effect was also demonstrated in our rat HPH model. Here, PPARG is linked to pulmonary arterial hypertension.